Informationen:
Fehler:
ID
13775
Beschreibung
Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations; ODM derived from: https://clinicaltrials.gov/show/NCT01470716
Link
https://clinicaltrials.gov/show/NCT01470716
Stichworte
Versionen (1)
- 06.03.16 06.03.16 -
Hochgeladen am
6. März 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-small Cell Lung Cancer Stage II NCT01470716
Eligibility Non-small Cell Lung Cancer Stage II NCT01470716
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-small Cell Lung Cancer Stage II NCT01470716
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
tumor stage non-small cell lung cancer
Item
pathologically confirmed stage ii & iiia non-small cell lung cancer
boolean
C1300072 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,2])
EGFR gene mutation
Item
egfr exon 19 or 21 mutations
boolean
C3266992 (UMLS CUI [1])
age; ecog
Item
age ≥ 18 years and ecog performance 0~1
boolean
C0001779 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C1520224 (UMLS CUI [2])
lesion
Item
has measurable lesion by recist 1.1
boolean
C0221198 (UMLS CUI [1])
chemotherapy; radiation therapy
Item
no previous chemotherapy or radiation therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Absolute neutrophil count; hemoglobin; platelet; pao2; Serum creatine; creatinine clearance; serum bilirubin; ast and alt; alkaline phosphatase
Item
adequate organ function by following; anc ≥1,500/ul, hemoglobin ≥9.0g/dl, platelet ≥100,000/ul, pao2 ≥ 60 mmhg, serum cr < 1 x unl or creatinine clearance > 60 ml/min, serum bilirubin < 1 x unl, ast (sgot) and alt (sgpt) < 2.5 x unl, alkaline phosphatase < 5 x unl
boolean
C0948762 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0202155 (UMLS CUI [4])
C0858112 (UMLS CUI [5])
C0373595 (UMLS CUI [6])
C0428441 (UMLS CUI [7])
C3831581 (UMLS CUI [8])
C0002059 (UMLS CUI [9])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0202155 (UMLS CUI [4])
C0858112 (UMLS CUI [5])
C0373595 (UMLS CUI [6])
C0428441 (UMLS CUI [7])
C3831581 (UMLS CUI [8])
C0002059 (UMLS CUI [9])
informed consent
Item
written informed consent form
boolean
C0021430 (UMLS CUI [1])
chemotherapy; radiation therapy
Item
previous chemotherapy or radiation therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
medical history malignancy; skin cancer; cervical cancer in situ
Item
previous history of malignancy within 5 years from study entry except treated non-melanomatous skin cancer or uterine cervical cancer in situ
boolean
C0262926 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0007114 (UMLS CUI [2])
C0742130 (UMLS CUI [3])
C0006826 (UMLS CUI [1,2])
C0007114 (UMLS CUI [2])
C0742130 (UMLS CUI [3])
hypersensitivity erlotinib
Item
known allergic history of erlotinib
boolean
C0020517 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C1135135 (UMLS CUI [1,2])
interstitial lung disease; Chest x-ray findings; Interstitial lung fibrosis
Item
interstitial lung disease or fibrosis on chest radiogram
boolean
C0206062 (UMLS CUI [1])
C1821150 (UMLS CUI [2])
C3887486 (UMLS CUI [3])
C1821150 (UMLS CUI [2])
C3887486 (UMLS CUI [3])
infection; cardiopulmonary insufficiency; arrhythmias; hepatitis
Item
active infection, uncontrolled systemic disease (cardiopulmonary insufficiency, fatal arrhythmias, hepatitis)
boolean
C3714514 (UMLS CUI [1])
C0920033 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
C0019158 (UMLS CUI [4])
C0920033 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
C0019158 (UMLS CUI [4])
pregnancy; lactating
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])